Zenas BioPharma (ZBIO) Income Statement: Revenue & Earnings

Zenas BioPharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Zenas BioPharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	5.00	50.00	0.00
Cost of Revenue	139.14	60.03	61.69
Gross Profit	-134.14	-10.03	-61.69
Operating Expenses
Research & Development	139.14	60.03	61.69
Selling, General & Administrative	29.75	17.11	13.51
Operating Expenses	29.75	17.11	13.51
Operating Income	-163.89	-27.15	-75.20
Other Income/Expense
Interest Income	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00
Other Income/Expense	7.33	0.52	-43.08
Income
Income Before Tax	-156.56	-36.82	-119.28
Income Tax Expense	0.43	0.30	0.00
Net Income	-156.99	-37.12	-119.28
Net Income - Continuous Operations	-156.99	-37.12	-119.28
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-163.75	-27.03	-75.12
EBIT	-163.89	-27.15	-75.20
Depreciation & Amortization	0.14	0.11	0.08
Earnings Per Share
Basic EPS	-4.00	-24.00	-80.00
Diluted EPS	-4.00	-24.00	-80.00
Basic Shares Outstanding	41.79	1.53	1.49
Diluted Shares Outstanding	41.79	1.53	1.49